Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Year: 2015
Type: article
Study design: Observational Study
Source: Journal of Thoracic Oncology
Authors: Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, Ming-Shyan Huang, Wu-Chou Su, Ruay-Sheng Lai, Chin-Chou Wang, Shih-Hsin Hsiao, Yu-Ching Lin, Ching-Liang Ho, Te-Chun Hsia, Ming-Fang Wu, Chun-Liang Lai, Kang-Yun Lee, Chih-Bin Lin, Diana Yu-Wung Yeh, Chi-Yuan Chuang, Fu-Kang Chang, Chun-Ming Tsai, Reury-Perng Perng, James Chih-Hsin Yang
Institutions: Taipei Veterans General Hospital, National Yang Ming University, Chang Gung University, Chang Gung Memorial Hospital, Taoyuan Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, National Taiwan University, National Taiwan University Hospital, Kaohsiung Medical University, Kaohsiung Medical University Chung-Ho Memorial Hospital, National Cheng Kung University Hospital, National Cheng Kung University, Kaohsiung Veterans General Hospital, Kaohsiung Chang Gung Memorial Hospital, Taipei Medical University Hospital, Chiayi Chang Gung Memorial Hospital, Tri-Service General Hospital, China Medical University, China Medical University Hospital, Chung Shan Medical University Hospital, Chung Shan Medical University, Tzu Chi University, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, Tzu Chi Foundation, Buddhist Tzu Chi General Hospital, Shin Kong WHS Memorial Hospital, Taipei City Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2062629045
